MAPT and Alzheimer disease: We then supplemented phospho-epitope pS199/S202-Tau define by antibody AT8 as another classical marker in general use for post-mortem staging of brain tauopathy in AD, although not for as CSF-biomarker in clinical diagnosis [11], [12], [60].